CVRx, Inc.
NMS: CVRXLive Quote
About CVRx, Inc.
Healthcare
Medical Devices
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
📊 Fundamental Analysis
CVRx, Inc. demonstrates a profit margin of -94.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 4.4% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -96.6%, which indicates that capital utilization is currently under pressure.
At a current price of $7.16, CVRX currently sits at the 41st percentile of its 52-week range (Range: $4.30 - $11.30).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$137.99M
Trailing P/E
--
Forward P/E
-4.03
Beta (5Y)
1.12
52W High
$11.30
52W Low
$4.30
Avg Volume
360K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App